Plant Variety Rights

(PVRs)

Experts in IP Protection for Plant Variety Inventions


Improvement of crop and ornamental species by genetic modification or modern breeding techniques remains a significant area of innovation. A number of IP rights may be suitable for protecting plant inventions, including patents, trade marks, plant Variety Rights (PVRs) and entry on the national list or common catalogue. Our experienced IP specialists are well placed to assist our clients in this area, having a wealth of practical experience.

In Europe, individual plant varieties that are distinct, uniform and stable can be protected either nationally or at European Community level. Separately, European and national patents can be obtained for plants and plant-related inventions which are not restricted to plant varieties per se, although certain plant breeding methods and plants obtained by those methods are excluded from patentability.  Despite the EU’s strict policies on growing genetically modified crops and uncertainty surrounding the use of genetic resources in plant breeding, there is considerable commercial interest in these technical areas and in IP protection for the output of biotech research and classical breeding programs.

Our expert IP team is led by Frances Salisbury, who has a PhD in plant molecular genetics. An expert in this field Frances has completed the official World Intellectual Property Organisation (WIPO) course on Plant Variety Protection under the UPOV Convention.

Read our Plant Variety Rights Law and Practice guide.

Read our blogs

Fast Growing Techbio: Data, Computational Research, IP and How to Leverage Those for Commercial Success

Fast Growing Techbio: Data, Computational Research, IP and How to Leverage Those for Commercial Success

by Christopher Casley

On Wednesday 6 May we were delighted to co-host a panel discussion and networking event: “Fast growing techbio: data, computational research, IP and how to leverage those for commercial success” at ...

PROTACs reach the market: what the first regulatory approval means for drug discovery and the patent landscape

PROTACs reach the market: what the first regulatory approval means for drug discovery and the patent landscape

by Andrew Pitts

Just as the attention of the pharmaceutical industry appeared to have shifted over the past few years towards biologics with blockbuster potential, a new and exciting therapeutic modality has emerged ...

Artificial Intelligence in Modern Fertility Technologies

Artificial Intelligence in Modern Fertility Technologies

by Charlotte Lynch

In vitro fertilisation (IVF) represented a major technological breakthrough when it first became available more than forty years ago. However, despite incremental improvements, overall IVF success ...

How Plurify is purifying cell pools with bespoke RNA

How Plurify is purifying cell pools with bespoke RNA

by Anja Koller

Forward speaks to Mantas Matjusaitis, Plurify co-founder and chief technical officer, tells Mewburn Ellis about the company’s method of sorting stem cells at bioreactor scale.

The quest to build heat-resistant vaccines

The quest to build heat-resistant vaccines

by Anja Koller

Forward speaks to Asel Sartbaeva, the co-inventor of a method to make temperature sensitive medicines withstand heat, with the potential to transform the way they are stored, transported and ...

The global boom in microbial crop solutions and what it means for your IP strategy

The global boom in microbial crop solutions and what it means for your IP strategy

by Ben Tolley

Experts predict that global food production will need to more than double in the next 25 years. There is no historical precedent for achieving growth of that magnitude in a single generation.

ME Forward Masthead White 2